Impact of CYP2D*6 in the adjuvant treatment of breast cancer patients with tamoxifen

doi:10.5306/wjco.v5.i3.374

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5904)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

373

WORD

209

HTML

3024

Figures (1-1)

235

Tables (1-1)

218

Sum=4059

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

924

Download

921

Sum=1845

Aug 10, 2014 (publication date) through Feb 4, 2025

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Clin Oncol. Aug 10, 2014; 5(3): 374-381
Published online Aug 10, 2014. doi: 10.5306/wjco.v5.i3.374

Full Size Figure Download Figure

Figure 1 Tamoxifen metabolism pathways.

Citation: Markopoulos C, Kykalos S, Mantas D. Impact of CYP2D*6 in the adjuvant treatment of breast cancer patients with tamoxifen. World J Clin Oncol 2014; 5(3): 374-381
URL: https://www.wjgnet.com/2218-4333/full/v5/i3/374.htm
DOI: https://dx.doi.org/10.5306/wjco.v5.i3.374